CHAPTER 306
An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes.
[S 379]
Approved April 6, 2026
Be it enacted by the General Assembly of Virginia:
1. § 1. Upon approval by the U.S. Food and Drug Administration (FDA) of a formulation of psilocybin designed to be administered by a health care professional in a health care setting, the Board of Pharmacy shall reschedule such formulation of psilocybin consistent with federal scheduling changes and procedures contained in subsection E of § 54.1-3443 of the Code of Virginia at its next quarterly meeting following the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule designating any formulation of psilocybin that has been approved by the FDA as a controlled substance.